Wed, October 20, 2021
Tue, October 19, 2021
Mon, October 18, 2021
Sun, October 17, 2021
Fri, October 15, 2021
Thu, October 14, 2021
Wed, October 13, 2021
Tue, October 12, 2021
Mon, October 11, 2021

Alethia Young Maintained (BIIB) at Hold with Decreased Target to $327 on, Oct 15th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-decreased-target-to-327-on-oct-15th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Alethia Young of Cantor Fitzgerald, Maintained "Biogen Inc." (BIIB) at Hold with Decreased Target from $427 to $327 on, Oct 15th, 2021.

Alethia has made no other calls on BIIB in the last 4 months.



There are 9 other peers that have a rating on BIIB. Out of the 9 peers that are also analyzing BIIB, 3 agree with Alethia's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $290 on, Friday, October 8th, 2021
  • Brian Abrahams of "RBC Capital" Maintained at Hold with Decreased Target to $326 on, Wednesday, September 29th, 2021
  • Salim Syed of "Mizuho" Maintained at Hold with Increased Target to $300 on, Monday, August 2nd, 2021


These are the ratings of the 6 analyists that currently disagree with Alethia


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $447 on, Tuesday, October 12th, 2021
  • Michael Yee of "Jefferies" Maintained at Strong Buy with Decreased Target to $400 on, Friday, October 8th, 2021
  • Ami Fadia of "Needham" Initiated at Strong Buy and Held Target at $400 on, Thursday, September 23rd, 2021
  • Colin Bristow of "UBS" Maintained at Strong Buy with Decreased Target to $442 on, Thursday, September 16th, 2021
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $423 on, Tuesday, July 27th, 2021
  • Christopher Raymond of "Piper Sandler" Upgraded from Hold to Buy and Increased Target to $450 on, Friday, June 18th, 2021

Publication Contributing Sources